The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Live Attenuated Polio Vaccine Market During The Forecast Period 2026–2030?
The live attenuated polio vaccine market has experienced significant expansion in recent years. It is projected to increase from $1.98 billion in 2025 to $2.13 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. This growth observed in the past can be credited to global polio eradication initiatives, the widespread adoption of oral polio vaccines, robust government-led immunization programs, early achievements in reducing polio transmission, and the backing of international health organizations.
The market for live attenuated polio vaccines is anticipated to experience robust expansion over the coming years, with projections indicating it will reach $2.85 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.6%. This expected growth during the forecast period is driven by ongoing eradication efforts in remaining endemic regions, an increasing focus on preventing outbreaks, the expansion of vaccination coverage into underserved populations, enhanced funding for public health immunization programs, and a growing emphasis on vaccine accessibility and affordability. Key trends for this period include the continued use of oral polio vaccines in mass immunization initiatives, a strong focus on fostering community-level immunity and controlling transmission, sustained demand in polio-endemic and high-risk areas, the integration of live attenuated polio vaccines (LAPV) into national immunization programs, and an increased emphasis on achieving long-lasting immunity in pediatric vaccination.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24280&type=smp
What Underlying Factors Are Accelerating The Growth Of The Live Attenuated Polio Vaccine Market?
The anticipated increase in immunization programs is projected to boost the live attenuated polio vaccine market’s growth in the future. These programs represent structured initiatives by governments, health agencies, or similar bodies to administer vaccines to populations, aiming to halt the spread of infectious diseases. This expansion is largely driven by a heightened global understanding of the significance of preventing diseases, alongside robust backing from governments, international health entities, and financial organizations. Immunization initiatives bolster the live attenuated polio vaccine (LAPV) through guaranteeing extensive distribution, secure delivery, and high population coverage, thereby fostering herd immunity, hindering virus transmission, and contributing to worldwide polio eradication. As an illustration, in May 2025, the UK Health Security Agency, a governmental body in the UK, reported that during the 2023–2024 season, a school program in England, aimed at children aged 4 to 16 years (Reception to Year 11), resulted in 52.2% of qualifying children from Reception to Year 9 (3,498,576 out of 6,708,016) receiving the vaccine. This figure represents a minor increase compared to the 51.9% coverage (3,502,566 out of 6,747,523) documented in the preceding 2022–2023 season. Consequently, the increased reach of immunization programs is propelling the expansion of the live attenuated polio vaccine market.
What Market Segments Are Evaluated Within The Live Attenuated Polio Vaccine Market?
The live attenuated polio vaccine market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Bivalent, Trivalent
2) By Age Group: Infants (0-1 years), Children (1-5 years)
3) By End-User: Clinics, Public Health Agencies, Other End-Users
Subsegments:
1) By Monovalent: mOPV1 For Serotype 1
2) By Bivalent: Type 1, Type 3
3) By Trivalent: Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3
What Key Trends Are Influencing The Development Of The Live Attenuated Polio Vaccine Market?
Major companies operating in the live attenuated polio vaccine market are focusing on obtaining regulatory clearances to ensure their vaccines fulfill the safety and efficacy standards required by health authorities globally. Regulatory approvals represent the formal authorization granted by government health agencies or regulatory bodies, allowing a product, such as a vaccine, to be marketed, sold, and used within a specific region or country. For instance, in July 2024, Biological E, an India-based pharmaceutical and biologics company, received approval from the World Health Organization (WHO) for its novel oral polio vaccine type 2 (nOPV2), an advanced live, attenuated oral vaccine developed to address the challenges associated with traditional oral polio vaccines. This next-generation vaccine is designed to combat circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks more effectively than its predecessor. nOPV2 is engineered with enhanced genetic stability, reducing the risk of the vaccine virus reverting to a virulent form, which has been a concern with older vaccines.
Who Are The Top Market Participants Influencing The Live Attenuated Polio Vaccine Market?
Major companies operating in the live attenuated polio vaccine market are Sanofi Pasteur, Serum Institute of India Pvt. Ltd., Biological E Limited, Indian Immunologicals Limited, Bharat Biotech International Limited, Panacea Biotec, Haffkine Biopharmaceutical, Bio Farma, Bilthoven Bio, Vabiotech, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., LG Chem Ltd., Chumakov Federal Scientific Center, Institute of Poliomyelitis and Viral Encephalitides, Statens Serum Institut, Federal State Unitary Enterprise Microgen, Pasteur Institute of Iran, Institut Pasteur de Dakar
Read the full live attenuated polio vaccine market report here:
https://www.thebusinessresearchcompany.com/report/live-attenuated-polio-vaccine-global-market-report
Which Region Is Projected To Dominate The Live Attenuated Polio Vaccine Market During The Forecast Period?
North America was the largest region in the live attenuated polio vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated polio vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Live Attenuated Polio Vaccine Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24280&type=smp
Browse Through More Reports Similar to the Global Live Attenuated Polio Vaccine Market 2026, By The Business Research Company
Conjugate Vaccine Global Market Report
https://www.thebusinessresearchcompany.com/report/conjugate-vaccine-global-market-report
Inactivated Vaccines Global Market Report
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Vaccines Global Market Report
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model